Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Baroudy

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Journal of Virology|October 24, 2000
Hepatitis C virus internal ribosome entry site (IRES) stem loop IIId contains a phylogenetically conserved GGG triplet essential for translation and IRES foldingR Jubin, N E Vantuno, J S Kieft, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 1992
Detection of acute hepatitis C virus infection by ELISA using a synthetic peptide comprising a structural epitopeG J Kotwal, B M Baroudy, I K Kuramoto, et al.
Journal of Medical Virology|January 1, 1990
Riboprobe assay for HDV RNA: a sensitive method for the detection of the HDV genome in clinical serum samplesA Smedile, K F Bergmann, B M Baroudy, et al.
Virology|January 1, 1989
Biologic and molecular genetic characteristics of a unique MCF virus that is highly leukemogenic in ecotropic virus-negative miceS K Chattopadhyay, B M Baroudy, K L Holmes, et al.
Pediatric Nephrology (Berlin, Germany)|February 1, 1995
Absence of hepatitis B and C viruses in pediatric idiopathic membranoproliferative glomerulonephritisM J Nowicki, T R Welch, N Ahmad, et al.
Virology|March 24, 1999
Generation of transmissible hepatitis C virions from a molecular clone in chimpanzeesZ Hong, M Beaudet-Miller, R E Lanford, et al.
Journal of Virology|February 7, 2001
Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3N Butkiewicz, N Yao, W Zhong, et al.
Journal of Medicinal Chemistry|October 5, 2001
Piperazine-based CCR5 antagonists as HIV-1 inhibitors. II. Discovery of 1-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4- methyl-4-[3(S)-methyl-4-[1(S)-[4-(trifluoromethyl)phenyl]ethyl]-1-piperazinyl]- piperidine N1-oxide (Sch-350634), an orally bioavailable, potent CCR5 antagonistJ R Tagat, R W Steensma, S W McCombie, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2001
SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivoJ M Strizki, S Xu, N E Wagner, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of Virology|October 24, 2000
Hepatitis C virus internal ribosome entry site (IRES) stem loop IIId contains a phylogenetically conserved GGG triplet essential for translation and IRES foldingR Jubin, N E Vantuno, J S Kieft, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 1992
Detection of acute hepatitis C virus infection by ELISA using a synthetic peptide comprising a structural epitopeG J Kotwal, B M Baroudy, I K Kuramoto, et al.
Journal of Medical Virology|January 1, 1990
Riboprobe assay for HDV RNA: a sensitive method for the detection of the HDV genome in clinical serum samplesA Smedile, K F Bergmann, B M Baroudy, et al.
Virology|January 1, 1989
Biologic and molecular genetic characteristics of a unique MCF virus that is highly leukemogenic in ecotropic virus-negative miceS K Chattopadhyay, B M Baroudy, K L Holmes, et al.
Pediatric Nephrology (Berlin, Germany)|February 1, 1995
Absence of hepatitis B and C viruses in pediatric idiopathic membranoproliferative glomerulonephritisM J Nowicki, T R Welch, N Ahmad, et al.
Virology|March 24, 1999
Generation of transmissible hepatitis C virions from a molecular clone in chimpanzeesZ Hong, M Beaudet-Miller, R E Lanford, et al.
Journal of Virology|February 7, 2001
Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3N Butkiewicz, N Yao, W Zhong, et al.
Journal of Medicinal Chemistry|October 5, 2001
Piperazine-based CCR5 antagonists as HIV-1 inhibitors. II. Discovery of 1-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4- methyl-4-[3(S)-methyl-4-[1(S)-[4-(trifluoromethyl)phenyl]ethyl]-1-piperazinyl]- piperidine N1-oxide (Sch-350634), an orally bioavailable, potent CCR5 antagonistJ R Tagat, R W Steensma, S W McCombie, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2001
SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivoJ M Strizki, S Xu, N E Wagner, et al.
Pageof 4